Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy

Stefano Scalera; Biagio Ricciuti; Daniele Marinelli; Marco Mazzotta; Laura Cipriani; Giulia Bon; Giulia Schiavoni; Irene Terrenato; Alessandro Di Federico; Joao V. Alessi; Maurizio Fanciulli; Ludovica Ciuffreda; Francesca De Nicola; Frauke Goeman; Giulio Caravagna; Daniele Santini; Ruggero De Maria; Federico Cappuzzo; Gennaro Ciliberto; Mariam Jamal-Hanjani; Mark M. Awad; Nicholas McGranahan; Marcello Maugeri-Saccà

doi:10.1101/2023.10.30.23297743

Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy

Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Giulia Schiavoni, Irene Terrenato, Alessandro Di Federico, Joao V. Alessi, Maurizio Fanciulli, Ludovica Ciuffreda, Francesca De Nicola, Frauke Goeman, Giulio Caravagna, Daniele Santini, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Mariam Jamal-Hanjani, Mark M. Awad, Nicholas McGranahan, Marcello Maugeri-Saccà

doi: https://doi.org/10.1101/2023.10.30.23297743

Stefano Scalera

1Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Biagio Ricciuti

2Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniele Marinelli

3Department of Experimental Medicine, Sapienza University, Rome, Italy.

4Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.

5Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marco Mazzotta

6Medical Oncology Unit, Sandro Pertini Hospital, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Laura Cipriani

1Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giulia Bon

7Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giulia Schiavoni

1Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irene Terrenato

1Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alessandro Di Federico

2Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joao V. Alessi

2Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maurizio Fanciulli

8SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ludovica Ciuffreda

8SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francesca De Nicola

8SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frauke Goeman

8SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giulio Caravagna

9Department of Mathematics and Geosciences, University of Trieste, Trieste, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniele Santini

10Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ruggero De Maria

11Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Federico Cappuzzo

12Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gennaro Ciliberto

13Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mariam Jamal-Hanjani

4Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark M. Awad

2Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicholas McGranahan

5Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcello Maugeri-Saccà

1Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

12Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: marcello.maugerisacca{at}ifo.it

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present work are contained in the manuscript

View the discussion thread.

PreviousNext

Posted December 14, 2023.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy

medRxiv 2023.10.30.23297743; doi: https://doi.org/10.1101/2023.10.30.23297743

Share This Article:

Citation Tools

Transcriptional phenocopies of deleterious KEAP1 mutations dictate survival outcomes in lung cancer treated with immunotherapy

medRxiv 2023.10.30.23297743; doi: https://doi.org/10.1101/2023.10.30.23297743

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Oncology

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)